Safi R. Bahcall
2009
In 2009, Safi R. Bahcall earned a total compensation of $869.2K as President and Chief Executive Officer at Synta Pharmaceuticals, a 16% decrease compared to previous year.
Compensation breakdown
| Bonus | $123,585 |
|---|---|
| Option Awards | $277,970 |
| Salary | $385,000 |
| Other | $82,674 |
| Total | $869,229 |
Bahcall received $385K in salary, accounting for 44% of the total pay in 2009.
Bahcall also received $123.6K in bonus, $278K in option awards and $82.7K in other compensation.
Rankings
In 2009, Safi R. Bahcall's compensation ranked 4,928th out of 9,885 executives tracked by ExecPay. In other words, Bahcall earned more than 50.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,928 out of 9,885 | 50th |
Division Manufacturing | 1,764 out of 3,690 | 52nd |
Major group Chemicals And Allied Products | 359 out of 866 | 59th |
Industry group Drugs | 222 out of 638 | 65th |
Industry Pharmaceutical Preparations | 170 out of 446 | 62nd |
Source: SEC filing on April 27, 2012.
Bahcall's colleagues
We found five more compensation records of executives who worked with Safi R. Bahcall at Synta Pharmaceuticals in 2009.
2009
Vojo Vukovic
Synta Pharmaceuticals
Chief Medical Officer
2009
Michael Bailey
Synta Pharmaceuticals
Senior Vice President, Business Development, Chief Business Officer
2009
Jeremy Chadwick
Synta Pharmaceuticals
Senior Vice President, Program Management and Clinical Operations
2009
Keizo Koya
Synta Pharmaceuticals
Senior Vice President, Drug Development
2009
Keith Ehrlich
Synta Pharmaceuticals